LARS Antibodies

Santa Cruz Biotechnology features a diverse variety of LARS Antibodies for investigating leucyl-tRNA synthetase (LARS) in cellular processes. LARS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Leucyl-tRNA synthetase plays an essential role in protein synthesis by catalyzing the attachment of leucine to its corresponding tRNA, ensuring accurate translation of genetic information into functional proteins. Beyond protein synthesis, LARS participates in various cellular signaling pathways and stress responses, maintaining cellular homeostasis and function. Research has shown that LARS activity influences multiple biological processes, from basic cellular functions to complex disease mechanisms. Investigating LARS expression and localization patterns can reveal new insights into cellular regulation and potential therapeutic targets. Understanding leucyl-tRNA synthetase dynamics opens possibilities for developing novel treatment strategies in conditions where protein synthesis is impaired. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of LARS biology and its implications in human health.